The resulting increased KLF4 transcriptional activity is responsible for the EndMT switch observed in CCM1‐null ECs, since it is able to drive the expression of both molecules responsible for TGFβ/BMP signaling activation and a number of EndMT markers involved in CCM pathogenesis. The gene discussed is TGFB1; the disease is cerebral cavernous malformation.